A 1 SER 23 -14.084 -15.109
A 2 ASP 0 -12.523 -11.082
A 3 LYS 12 -15.391 -15.001
A 4 ILE 18 -19.087 -18.962
A 5 ILE 22 -17.766 -18.253
A 6 HIS 7 -16.231 -15.169
A 7 LEU 32 -16.675 -18.437
A 8 THR 2 -11.642 -10.533
A 9 ASP 10 -9.684 -9.720
A 10 ASP 1 -5.882 -5.321
A 11 SER 15 -10.129 -10.690
A 12 PHE 24 -14.915 -15.960
A 13 ASP 4 -10.921 -10.125
A 14 THR 7 -11.192 -10.710
A 15 ASP 20 -16.119 -16.565
A 16 VAL 31 -19.180 -20.539
A 17 LEU 11 -16.586 -15.943
A 18 LYS 8 -12.577 -12.051
A 19 ALA 25 -16.468 -17.449
A 20 ASP 1 -16.526 -14.741
A 21 GLY 13 -19.432 -18.692
A 22 ALA 23 -23.025 -23.022
A 23 ILE 26 -24.628 -24.786
A 24 LEU 34 -25.855 -26.792
A 25 VAL 36 -24.016 -25.394
A 26 ASP 30 -22.006 -22.925
A 27 PHE 30 -18.737 -20.032
A 28 TRP 22 -15.816 -16.527
A 29 ALA 16 -10.977 -11.555
A 30 GLU 3 -6.663 -6.242
A 31 TRP 6 -5.886 -5.899
A 32 CYS 26 -9.914 -11.764
A 33 GLY 9 -6.418 -6.715
A 34 PRO 9 -3.600 -4.221
A 35 ILE 5 -2.259 -2.574 <=B
A 36 GLU 4 -0.580 -0.973 <=B
A 37 GLU 0 -0.589 -0.521 <=B
A 38 SER 0 0.135 0.120 <=B
A 39 ASP 11 -1.294 -2.410 <=B
A 40 ASP 0 -0.808 -0.715 <=B
A 41 ARG 12 -4.054 -4.968
A 42 ARG 7 -5.815 -5.951
A 43 TYR 23 -11.295 -12.641
A 44 ASP 10 -13.649 -13.229
A 45 LEU 36 -19.528 -21.422
A 46 VAL 16 -18.047 -17.811
A 47 GLY 10 -14.196 -13.714
A 48 PRO 24 -17.783 -18.498
A 49 CYS 27 -21.418 -22.060
A 50 LYS 5 -17.199 -15.796
A 51 MET 13 -15.269 -15.008
A 52 ILE 26 -18.726 -19.562
A 53 ALA 16 -19.107 -18.750
A 54 PRO 5 -14.339 -13.265
A 55 ILE 16 -14.904 -15.030
A 56 LEU 30 -19.790 -20.964
A 57 ASP 8 -17.461 -16.373
A 58 GLU 1 -16.103 -14.366
A 59 ILE 12 -19.787 -18.892
A 60 LEU 31 -23.604 -24.455
A 61 THR 22 -23.380 -23.222
A 62 VAL 25 -23.554 -23.721
A 63 ALA 35 -21.942 -23.444
A 64 LYS 21 -19.473 -19.648
A 65 LEU 34 -17.310 -19.229
A 66 ASN 7 -13.689 -12.920
A 67 ILE 22 -11.855 -13.022
A 68 ASP 6 -7.168 -7.034
A 69 GLN 15 -7.088 -7.997
A 70 ASN 23 -8.942 -10.559
A 71 PRO 2 -7.325 -6.713
A 72 GLY 9 -7.098 -7.317
A 73 THR 32 -12.291 -14.558
A 74 ALA 21 -14.376 -15.137
A 75 PRO 6 -8.946 -8.607
A 76 LYS 19 -8.248 -9.484
A 77 TYR 34 -15.586 -17.703
A 78 GLY 5 -11.356 -10.625
A 79 ILE 31 -14.690 -16.566
A 80 ARG 1 -9.694 -8.694
A 81 GLY 8 -11.581 -11.169
A 82 ILE 24 -14.402 -15.506
A 83 PRO 25 -16.985 -17.907
A 84 THR 22 -19.925 -20.163
A 85 LEU 28 -23.230 -23.778
A 86 LEU 29 -24.174 -24.729
A 87 LEU 23 -25.671 -25.364
A 88 PHE 28 -23.529 -24.043
A 89 LYS 11 -20.743 -19.623
A 90 ASN 1 -17.597 -15.688
A 91 GLY 8 -17.497 -16.404
A 92 GLU 4 -17.851 -16.258
A 93 VAL 16 -20.771 -20.222
A 94 ALA 25 -21.311 -21.735
A 95 ALA 21 -23.325 -23.057
A 96 THR 14 -22.184 -21.243
A 97 LYS 23 -21.086 -21.306
A 98 VAL 7 -18.428 -17.114
A 99 GLY 4 -16.525 -15.084
A 100 ALA 17 -16.473 -16.534
A 101 LEU 30 -18.709 -20.007
A 102 SER 2 -15.000 -13.505
A 103 LYS 9 -15.517 -14.768
A 104 GLY 0 -13.809 -12.221
A 105 GLN 13 -17.031 -16.567
A 106 LEU 30 -21.695 -22.650
A 107 LYS 11 -19.035 -18.111
A 108 GLU 7 -17.126 -15.962
A 109 PHE 31 -22.168 -23.183
A 110 LEU 29 -24.193 -24.746
A 111 ASP 9 -19.055 -17.899
A 112 ALA 12 -19.113 -18.295
A 113 ASN 25 -21.954 -22.305
A 114 LEU 23 -21.553 -21.719
A 115 ALA 6 -16.641 -15.418

Identified 6 B-Cell epitope residues out of 115 total residues